Logo image of AMIX

AUTONOMIX MEDICAL INC (AMIX) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:AMIX - US05330T2050 - Common Stock

0.5226 USD
-0.01 (-1.4%)
Last: 1/15/2026, 3:24:01 PM

AMIX Key Statistics, Chart & Performance

Key Statistics
Market Cap3.60M
Revenue(TTM)N/A
Net Income(TTM)-16.69M
Shares6.89M
Float6.41M
52 Week High3.33
52 Week Low0.47
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-5.72
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2024-01-29
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
AMIX short term performance overview.The bars show the price performance of AMIX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

AMIX long term performance overview.The bars show the price performance of AMIX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AMIX is 0.5226 USD. In the past month the price decreased by -20.08%. In the past year, price decreased by -83.12%.

AUTONOMIX MEDICAL INC / AMIX Daily stock chart

AMIX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AMIX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AMIX. No worries on liquidiy or solvency for AMIX as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AMIX Financial Highlights

Over the last trailing twelve months AMIX reported a non-GAAP Earnings per Share(EPS) of -5.72. The EPS increased by 63.77% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -210.43%
ROE -258.98%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%44.13%
Sales Q2Q%N/A
EPS 1Y (TTM)63.77%
Revenue 1Y (TTM)N/A

AMIX Forecast & Estimates

8 analysts have analysed AMIX and the average price target is 6.73 USD. This implies a price increase of 1188.17% is expected in the next year compared to the current price of 0.5226.


Analysts
Analysts85
Price Target6.73 (1187.79%)
EPS Next Y-77.46%
Revenue Next YearN/A

AMIX Ownership

Ownership
Inst Owners4.78%
Ins Owners5.18%
Short Float %2.09%
Short Ratio0.02

AMIX Latest News, Press Relases and Analysis

About AMIX

Company Profile

AMIX logo image Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. The company is headquartered in The Woodlands, Texas and currently employs 8 full-time employees. The company went IPO on 2024-01-29. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The firm is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Company Info

AUTONOMIX MEDICAL INC

21 Waterway Ave, Suite 300

The Woodlands TEXAS US

Employees: 10

AMIX Company Website

AMIX Investor Relations

Phone: 18322777816

AUTONOMIX MEDICAL INC / AMIX FAQ

Can you describe the business of AUTONOMIX MEDICAL INC?

Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. The company is headquartered in The Woodlands, Texas and currently employs 8 full-time employees. The company went IPO on 2024-01-29. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The firm is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.


What is the current price of AMIX stock?

The current stock price of AMIX is 0.5226 USD. The price decreased by -1.4% in the last trading session.


Does AUTONOMIX MEDICAL INC pay dividends?

AMIX does not pay a dividend.


What is the ChartMill technical and fundamental rating of AMIX stock?

AMIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Would investing in AUTONOMIX MEDICAL INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AMIX.


What is AUTONOMIX MEDICAL INC worth?

AUTONOMIX MEDICAL INC (AMIX) has a market capitalization of 3.60M USD. This makes AMIX a Nano Cap stock.